Document Detail

Hypermethylation of SHP-1 promoter in patient with high-risk myelodysplastic syndrome and it predicts poor prognosis.
MedLine Citation:
PMID:  22258937     Owner:  NLM     Status:  Publisher    
To study the role of SHP-1 methylation in the pathogenesis of myelodysplastic syndromes (MDS), we detect the methylation status of SHP-1 promoter and STAT3 phosphorylation of MDS patients by the methylation-specific PCR and Western blotting, respectively. It is found that the methylation rate of SHP-1 promoter of high-risk MDS patients (69.2%) was higher than that of the low-risk MDS patients (21.4%) (P = 0.001). The expression rate of STAT3 phosphorylated protein of high-risk group was higher (66.7%), when compared with that of the low-risk group (18.2%) (P = 0.0001). Correlation analysis showed that the methylation status of SHP-1 promoter is positive correlated with the expression of phosphorylated STAT3 in MDS patient (P < 0.001, r = 0.55). Interestingly, in high-risk group, the Kaplan-Meier analysis showed that the 3-year overall survival rate of high-risk MDS patients with SHP-1 methylation was lower than that of patient without SHP-1 methylation (25% vs. 61%) (P = 0.033). In summary, it is indicated that the SHP-1 methylation plays important role in the pathogenesis of MDS via activating the JAK/STAT pathway probably and the methylation of SHP-1 promoter is a useful prognostic factor for high-risk MDS patient, with the characteristic of higher methylation lower survival rate.
Yizhuo Zhang; Dandan Zhao; Haifeng Zhao; Xiaoxiong Wu; Weipeng Zhao; Yafei Wang; Bing Xia; Wanming Da
Related Documents :
2521867 - Functional study of t lymphocyte responsiveness in patients with dementia of the alzhei...
1654197 - Analysis of beta, gamma, and delta t-cell receptor genes in mycosis fungoides and sezar...
17209847 - Infliximab regulates lamina propria t lymphocytes in patients with crohn's disease.
311447 - Mitogen responsiveness and suppressor cell function in multiple sclerosis. influence of...
8447267 - Endocardial mapping during sinus rhythm in patients with coronary artery disease and no...
18358937 - A prospective clinical trial evaluating urinary 5-hydroxyindoleacetic acid levels in th...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-19
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  -     ISSN:  1559-131X     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Hematology, Tianjin Cancer Hospital and Institute, Tianjin Medical University, Tianjin, 300060, People's Republic of China,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Erythropoietin-Coated ZP-Microneedle Transdermal System: Preclinical Formulation, Stability, and Del...
Next Document:  Amnioinfusion for potential or suspected umbilical cord compression in labour.